23andMe SPAC Presentation Deck

0.9 FY15A Investing in Our Future Note: Fiscal year ends March 31. 1.3 FY16A 2.0 FY17A 4.4 FY18A Cumulative Genotyped Customers in M 7.8 FY19A 9.8 FY20A 11.2 FY21E Customer Acquisition Cost "Anyone trying to replicate the 23andMe model by focusing only on the data, and neglecting the central focus on empowered, engaged patients, is likely to fail – and never understand why." David Shaywitz Forbes Magazine 23and Me Confidential and Proprietary Information 31

View entire presentation